tislelizumab (Tevimbra®)
Application Details
HSE100107
26021
tislelizumab
Tevimbra®
BeOne Medicines Ireland Limited
11/05/2026
21/08/2025
Application Status
Applicant Meeting Held with CPU
06/08/2026
Rapid Review Completed
17/06/2026
Rapid Review Commissioned
12/05/2026
Pricing and Reimbursement Application Complete
11/05/2026